We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
+4.38%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$567M
AUM Growth
+$17.2M
Cap. Flow
+$1.05M
Cap. Flow %
0.19%
Top 10 Hldgs %
26.48%
Holding
199
New
9
Increased
67
Reduced
61
Closed
15

Top Buys

Rank Stock Value
1
HSY icon
Hershey
HSY
+$13.1M
2
PX
Praxair Inc
PX
+$4.09M
3
DIS icon
Walt Disney
DIS
+$3.29M
4
META icon
Meta Platforms (Facebook)
META
+$3.25M
5
DHR icon
Danaher
DHR
+$2.96M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$8.14M
2
PG icon
Procter & Gamble
PG
+$6.45M
3
CVS icon
CVS Health
CVS
+$5.02M
4
MDT icon
Medtronic
MDT
+$4.36M
5
PRGO icon
Perrigo
PRGO
+$4.15M

Sector Composition

Rank Sector Weight
1 Technology 17.28%
2 Healthcare 15.71%
3 Financials 15.64%
4 Consumer Staples 9.48%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECL icon
101
Ecolab
ECL
$78.4B
$838K 0.15%
7,152
+82
+1% +$9.6K
R icon
102
Ryder
R
$9.97B
$809K 0.14%
10,863
+16
+0.1% +$1.18K
INSM icon
103
Insmed
INSM
$21.4B
$794K 0.14%
60,029
JAZZ icon
104
Jazz Pharmaceuticals
JAZZ
$15.8B
$780K 0.14%
7,150
RARE icon
105
Ultragenyx Pharmaceutical
RARE
$2.46B
$735K 0.13%
10,450
-50
-0.5% -$3.55K
ARLZ
106
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$735K 0.13%
166,733
SBR
107
Sabine Royalty Trust
SBR
$1.06B
$703K 0.12%
20,000
CAT icon
108
Caterpillar
CAT
$384B
$666K 0.12%
7,180
-148
-2% -$13.4K
SCG
109
DELISTED
Scana
SCG
$664K 0.12%
9,055
-84
-0.9% -$6K
SE
110
DELISTED
Spectra Energy Corp Wi
SE
$662K 0.12%
16,108
+159
+1% +$6.59K
IONS icon
111
Ionis Pharmaceuticals
IONS
$9.02B
$651K 0.11%
13,612
KYNB
112
Kyntra Bio
KYNB
$27.8M
$642K 0.11%
1,200
ADXS
113
DELISTED
Advaxis Inc
ADXS
$629K 0.11%
5,853
-227
-4% -$30.6K
PM icon
114
Philip Morris
PM
$294B
$619K 0.11%
6,766
-116
-2% -$10.7K
RGEN icon
115
Repligen
RGEN
$8.29B
$616K 0.11%
20,000
GWW icon
116
W.W. Grainger
GWW
$64.9B
$600K 0.11%
2,585
-115
-4% -$25.7K
DD icon
117
DuPont de Nemours
DD
$19.1B
$555K 0.1%
3,829
-100
-3% -$13.9K
BSM icon
118
Black Stone Minerals
BSM
$3.16B
$526K 0.09%
28,000
BNCN
119
DELISTED
BNC Bancorp
BNCN
$523K 0.09%
16,407
-1,000
-6% -$28.1K
QCOM icon
120
Qualcomm
QCOM
$159B
$497K 0.09%
7,616
+1,130
+17% +$75.9K
ITW icon
121
Illinois Tool Works
ITW
$83B
$490K 0.09%
4,000
-109
-3% -$13.2K
LOW icon
122
Lowe's Companies
LOW
$119B
$490K 0.09%
6,887
-538
-7% -$38.1K
GM icon
123
General Motors
GM
$79.6B
$488K 0.09%
13,997
-1,380
-9% -$46.4K
LMT icon
124
Lockheed Martin
LMT
$135B
$479K 0.08%
1,916
+665
+53% +$166K
COP icon
125
ConocoPhillips
COP
$145B
$474K 0.08%
9,448
-908
-9% -$41.9K

Similar funds

Franklin Street Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Franklin Street Advisors held 199 positions worth $567M, up 3.1% from $550M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Franklin Street Advisors's Q4 2016 filing shows 9 new, 67 increased, 61 reduced and 15 closed positions. Its largest new stake was Hershey: 132,510 shares worth $13.7M. The largest sale was Gilead Sciences, an estimated $8.14M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Franklin Street Advisors's largest Q4 2016 buy was Hershey: 132,510 shares worth $13.7M.
  • Franklin Street Advisors added most to Praxair Inc in Q4 2016, an estimated $4.09M increase.
  • Franklin Street Advisors's biggest Q4 2016 reduction was Gilead Sciences, cutting an estimated $8.14M.
  • Franklin Street Advisors fully exited CVS Health in Q4 2016, selling an estimated $5.02M.
  • Franklin Street Advisors's ten largest holdings make up 26% of its $567M portfolio in Q4 2016.
  • Franklin Street Advisors opened 9 new positions and closed 15 in Q4 2016.
  • Franklin Street Advisors's portfolio value rose 3.1% quarter-over-quarter to $567M.

Based on Franklin Street Advisors's 13F filing for Q4 2016, filed 10 Jan 2017.